Recent Comments

Comment RSS

Zyban News and Research RSS Feed - Zyban News and Research

Bupropion (previously known as amfebutamone; Wellbutrin, Zyban) is an atypical antidepressant that acts as a norepinephrine and dopamine reuptake inhibitor, and nicotinic antagonist. Bupropion belongs to the chemical class of aminoketones and is similar in structure to the stimulant cathinone, to the anorectic diethylpropion, and to phenethylamines in general. Initially researched and marketed as an antidepressant, bupropion was subsequently found to be effective as a smoking cessation aid.

Development of VLN cigarettes for use in smoking cessation continues: 22nd Century

28. October 2009 05:42
22nd Century Limited, LLC is pleased to announce that it is continuing development of a very low nicotine cigarette for use in smoking cessation. Clinical trial results demonstrate that these cigarettes, also referred to as ‘nicotine-free’ and ‘denicotinized,’ may be more effective for quitting than FDA-approved therapies. [More]

Chantix and Zyban to get boxed warnings on serious mental health events

1. July 2009 21:56
The U.S. Food and Drug Administration has announced that it is requiring manufacturers to put a Boxed Warning on the prescribing information for the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion). The warning will highlight the risk of serious mental health events including changes in behavior, depressed mood, hostility, and suicidal thoughts when taking these drugs. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , ,

Researchers study effect of ADHD on smoking cessation

21. November 2008 22:32
Tobacco use is more prevalent and smoking cessation less likely among persons with Attention Deficit Hyperactivity Disorder (ADHD). [More]

Distinct clusters of genetic markers linked to treatment responses for smoking cessation

2. June 2008 16:22
Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), was published in the June issue of the journal Archives of General Psychiatry. [More]

When your antidepressants don't work

26. March 2008 07:01
should you switch to a different medication from the same class or should you try an antidepressant medication that has a different mechanism of action? [More]

Link between genetic variant and effectiveness of smoking cessation meds

11. September 2007 11:26
A genetic variant present in nearly half of Americans of European ancestry is linked to greater effectiveness of the smoking cessation medication bupropion (Zyban), according to research by scientists supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). [More]

Posted in: Drug Trial News

Tags: , , , , , ,

Who's still smoking?

22. August 2007 13:25
Quitting smoking is not easy, but thousands of New Yorkers succeed at it every year. Who's trying to kick the habit, and who's succeeding? In a new report titled Who's Still Smoking?, the Health Department sheds light on both questions. [More]

Posted in: Miscellaneous News

Tags: , , , , , , , ,

FDA - all antidepressants need new warning labels

3. May 2007 06:48
The Food and Drug Administration (FDA) in the United States wants the manufacturers of antidepressant medications to change the labels on their products. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , , ,

Chantix versus Zyban

25. February 2007 14:27
Researchers in the United States say smokers who fail to quit smoking by using pills, should not be disheartened and should try again. [More]

Posted in: Drug Trial News

Tags: , , , , , , , , ,

New anti-smoking drug Varenicline (Chantix) promotes longer-lasting abstinence

5. July 2006 18:08
Scientists have found that a new anti-smoking drug may be more effective than drugs currently in use to help smokers kick the habit and it has the added advantage of promoting longer-lasting abstinence. [More]

Chantix new quit smoking drug approved

11. May 2006 18:06
The U.S. Food and Drug Administration (FDA) has given approval for the sale of the first smoking cessation drug in almost ten years. [More]

Varenicline could increase number who quit smoking

3. May 2006 09:40
Smokers who try to quit using existing medications, such as nicotine patches or Zyban, are about twice as likely to succeed as those who don't use medication or are prescribed placebos during clinical trials. [More]

Psychiatric patients who smoke

10. January 2006 08:17
An editorial in the January 2006 issue of the Psychiatric Bulletin reviews the evidence for the effectiveness of gene-based smoking cessation packages, and asks whether they are appropriate for psychiatric patients. [More]

New drug far more effective in stopping smokers lighting up

16. November 2005 17:35
An experimental smoking cessation drug by Pfizer apparently gives smokers better odds at kicking the habit. [More]

Killer secondhand smoke campaign flares up in the UK

6. September 2005 10:21
According to new research by the National Health Service (NHS), 60 per cent of smokers light up and smoke without asking for permission, despite the fact that most non-smokers mind if other people are smoking nearby. [More]

Posted in: Medical Research News

Tags: , , , , , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.